PTAB
AIA trial proceedings.
Inter Partes Review, Post-Grant Review, and Covered Business Method proceedings at the USPTO Patent Trial and Appeal Board. Refreshed every six hours from the USPTO decisions feed, so outcomes track through institution, settlement, and the final written decision — where we read the claim-level result (invalidated vs sustained) straight from the decision. Each proceeding links to the patent it’s challenging — when we have a dossier on file, the row jumps to it directly.
1,113 proceedings indexed · 29 match this filter.
By industry
Software Technology & Computing Systems (T)(238)High-Tech (T)(220)Medical (M)(142)Semiconductor (T)(58)Automotive (A)(41)Energy (E)(37)Industrial Manufacturing (IM)(30)Wireless Technologies(29)Home Appliance (HA)(12)Sporting Goods (S)(11)Audio Technology(9)Financial Technology (FT)(9)Gaming (G)(8)Footwear(6)Baby Products(5)Media & Broadcasting (T)(5)Agriculture (AG)(4)Audience Measurement(3)Lighting (L)(3)Firearms (F)(2)Food (FD)(2)Optical Technology(2)Other (O)(2)Plumbing(2)Railroad(2)Tech (T)(2)Consumer Durables(1)Cosmetics (C)(1)Home Security(1)Vaping (V)(1)Biotechnology(0)Furniture (F)(0)Logistics (L)(0)Logistics & Shipping(0)Optical Communication(0)Software Technology (T)(0)
| Proceeding | Patent | Filed | Petitioner | Patent owner | Status |
|---|---|---|---|---|---|
| PGR2025-00013PGR | US 11938082 | Dec 23, 2024 | Therabody, Inc. | Hyperice IP Subco, LLC et al. | Claims 1-16, 18 sustained |
| IPR2025-00349IPR | US 10123074 | Dec 20, 2024 | Stingray Group Inc. et al. | Hernandez-Mondragon, Edwin et al. | Claims 1-21 sustained |
| IPR2025-00255IPR | US 9633139 | Dec 20, 2024 | Microsoft Corporation et al. | X1 Discovery, Inc. | Claims 1-27 sustained |
| IPR2025-00254IPR | US 10552490 | Dec 20, 2024 | Microsoft Corporation et al. | X1 Discovery, Inc. | Claims 1-20 sustained |
| IPR2025-00253IPR | US 7370035 | Dec 19, 2024 | Microsoft Corporation et al. | X1 Discovery, Inc. | Claims 1-10 sustained |
| IPR2025-00321IPR | US 9421713 | Dec 17, 2024 | Shenzhen Tuozhu Technology Co., Ltd. et al. | Stratasys, Inc. et al. | Claims 1, 2, 5, 6, 7, 9, 16, 17 sustained |
| IPR2025-00160IPR | US 11786680 | Dec 6, 2024 | ResMed Corp. | Cleveland Medical Devices, Inc. | Claims 1-5, 7, 8, 10-13, 15-18, 20-31 sustained |
| IPR2025-00159IPR | US 11375921 | Dec 6, 2024 | ResMed Corp. | Cleveland Medical Devices, Inc. | Claims 1, 2, 4, 5, 7-9, 11-14, 16 sustained |
| IPR2025-00158IPR | US 11690512 | Dec 6, 2024 | ResMed Corp. | Cleveland Medical Devices, Inc. | Claims 1-20 sustained |
| IPR2025-00232IPR | US 10276207 | Dec 4, 2024 | Rode Microphones, LLC et al. | Zaxcom, Inc. | Claims 1-4, 7-9, 15, 17, 19, 20, 22-27 (Patent 7,711,443); 17-19, 21-23, 33, 34, 59, 60, 66 (Patent 10,276,207) sustained |
| IPR2025-00230IPR | US 7711443 | Dec 4, 2024 | Rode Microphones, LLC et al. | Zaxcom, Inc. | Claims 1-4, 7-9, 15, 17, 19, 20, 22-27 (Patent 7,711,443); 17-19, 21-23, 33, 34, 59, 60, 66 (Patent 10,276,207) sustained |
| IPR2025-00116IPR | US 11754077 | Nov 27, 2024 | Abbott Laboratories et al. | MIRACOR MEDICAL SA | Claims 1-5, 7, 10, 16-24, 26, 28 sustained |
| IPR2025-00219IPR | US 9706500 | Nov 26, 2024 | Tesla, Inc. | Intellectual Ventures II | Claims 11-22 sustained |
| IPR2025-00217IPR | US 10952153 | Nov 26, 2024 | Tesla, Inc. | Intellectual Ventures II | Claims 1-5, 10-15, 20 sustained |
| IPR2025-00118IPR | US 10879164 | Nov 14, 2024 | Micron Technology, Inc. et al. | Yangtze Memory Technologies Company, Ltd. | Claims 1-14 sustained |
| IPR2025-00094IPR | US 8264003 | Nov 14, 2024 | Innoscience America, Inc. et al. | Infineon Technologies Americas Corp. | Claims 1-16 sustained |
| IPR2025-00109IPR | US 11874910 | Nov 7, 2024 | Jumio Corporation | FaceTec, Inc. | Claims 1-24 sustained |
| IPR2025-00108IPR | US 11693938 | Nov 7, 2024 | Jumio Corporation | FaceTec, Inc. | Claims 1-24 sustained |
| IPR2025-00107IPR | US 11157606 | Nov 7, 2024 | Jumio Corporation | FaceTec, Inc. | Claims 1-20 sustained |
| IPR2025-00106IPR | US 10776471 | Nov 7, 2024 | Jumio Corporation | FaceTec, Inc. | Claims 1-20 sustained |
| IPR2025-00058IPR | US 9158494 | Oct 17, 2024 | Google LLC et al. | Multifold International Incorporated Pte. Ltd. | Claims 1, 2, 4, 6, 9, 10, 12, 13, 14, 18, 19, 20 sustained |
| IPR2025-00016IPR | US 10876108 | Oct 4, 2024 | Integrated DNA Technologies, Inc. et al. | Tecan Group AG | Claims 1-3, 5-12, 14-19 sustained |
| IPR2025-00015IPR | US 10036012 | Oct 4, 2024 | Integrated DNA Technologies, Inc. et al. | Tecan Group AG | Claims 1-3, 5-22 sustained |
| IPR2024-01419IPR | US 11840730 | Sep 30, 2024 | Illumina, Inc. | Molecular Loop Biosciences, Inc. | Claims 1-9 sustained |
| PGR2024-00053PGR | US 11857482 | Sep 27, 2024 | Therabody, Inc. | Hyperice IP Subco, LLC et al. | Claims 34-38, 40, 41, 43-46, 58-60 sustained |
| IPR2024-01494IPR | US 11968909 | Sep 27, 2024 | Western Digital Technologies, Inc. et al. | Godo Kaisha IP Bridge 1 | Claims 5, 6, 9-20 sustained |
| IPR2024-01381IPR | US 11014090 | Sep 6, 2024 | CMS CEPCOR LTD et al. | Sandvik Intellectual Property AB et al. | Claims 1-14 sustained |
| IPR2022-01094IPR | US 8620039 | Jun 13, 2022 | ASSA ABLOY AB et al. | CPC Patent Technologies PTY Ltd. | Claims 3-12, 15-18 sustained |
| IPR2022-01093IPR | US 8620039 | Jun 13, 2022 | ASSA ABLOY AB et al. | CPC Patent Technologies PTY Ltd. | Claims 13-14 sustained |